GPC3 and hepatocellular carcinoma: An early group has suggested that miR-219 was significantly downregulated in hepatocellular carcinoma, also exerted tumor-suppressive effects in hepatic carcinogenesis via inhibiting transcription and translation of glypican-3 [22].